Biology Reference
In-Depth Information
479. Innominato PF, Levi FA, Bjarnason GA. Chronotherapy and the molecular clock: clin-
ical implications in oncology. Adv Drug Deliv Rev . 2010;62(9-10):979-1001.
480. Giacchetti S, Dugue PA, Innominato PF, et al. Sex moderates circadian chemotherapy
effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann
Oncol . Dec 2012;23(12):3110-3116.
481. Rivard GE, Infante-Rivard C, Dresse MF, Leclerc JM, Champagne J. Circadian time-
dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-
term follow-up study of survival. Chronobiol Int . Jun 1993;10(3):201-204.
482. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA
Cancer J Clin . 2011;61(2):69-90.
483. Saunders NA, Simpson F, Thompson EW, et al. Role of intratumoural heterogeneity
in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med . 2012;4
(8):675-684.
484. Stein CJ, Colditz GA. Modifiable risk factors for cancer. Br J Cancer . 2004;90
(2):299-303.
485. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-
epidemiology, risk factors, and genetics. BMJ . 2000;321(7261):624-628.
 
Search WWH ::




Custom Search